Close Menu

SAN FRANCISCO (GenomeWeb) - The 36th annual JP Morgan Healthcare Conference kicked off here on Monday with some of the life science tools and molecular diagnostics industries heavyweights presenting. Below are brief reports on the presentations and breakout sessions covered by our team at the conference.

Genomic Health

Following an expected profitable 2017, Genomic Health CEO Kim Popovits said that the company expects to record another profit in 2018 fueled by anticipated double-digit growth in 2018 revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.